Will Eylea, Dupixent Aid Regeneron’s (REGN) Q4 Earnings?

Posted byZacks Equity Research Leave a comment on Will Eylea, Dupixent Aid Regeneron’s (REGN) Q4 Earnings?

Regeneron’s (REGN) fourth-quarter performance might have gotten a boost from the solid performance of Eylea and Dupixent and incremental contribution from its antibody cocktail.

Leave a comment

Your email address will not be published. Required fields are marked *